Transduction patterns of pseudotyped lentiviral vectors in the nervous system

Molecular Therapy

Volumn 9, Issue 1, 2004, Pages 101-111

  Wong, Liang Fong ^a   Azzouz, Mimoun ^a   Walmsley, Lucy E ^a   Askham, Zoe ^a   Wilkes, Fraser J ^a   Mitrophanous, Kyriacos A ^a   Kingsman, Susan M ^a   Mazarakis, Nicholas D ^a  

^a OXFORD BIOMEDICA UK LTD   (United Kingdom)

Author keywords

EIAV; Gene therapy; Lentivirus; Pseudotyping; Retrograde transport

Indexed keywords

ENVELOPE PROTEIN; LENTIVIRUS VECTOR; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARENAVIRUS; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; CORPUS STRIATUM; EQUINE INFECTIOUS ANEMIA VIRUS; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; INJECTION; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; MALE; MUSCLE; NERVE FIBER TRANSPORT; NEUROLOGIC DISEASE; NONHUMAN; PERIPHERAL NERVOUS SYSTEM; RABIES VIRUS; RAT; RHABDOVIRUS; SEROTYPE; SPINAL CORD; STRAIN DIFFERENCE; VIRAL GENE DELIVERY SYSTEM; WILD TYPE;

ANIMALIA; ARENAVIRUS; CHORIOMENINGITIS VIRUS; EQUIDAE; EQUINE INFECTIOUS ANEMIA VIRUS; LENTIVIRUS; LYMPHOCYTIC CHORIOMENINGITIS VIRUS; LYSSAVIRUS; MOKOLA VIRUS; PRIMATES; RABIES VIRUS; RHABDOVIRIDAE; VESICULAR STOMATITIS VIRUS;

EID: 1142299570     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ymthe.2003.09.017     Document Type: Article

References (39)

1. Mazarakis, N. D., et al. (2001). Rabies virus glycoprotein pseudotyping of lentiviral vectors enables retrograde axonal transport and access to the nervous system after peripheral delivery. Hum. Mol. Genet. 10: 2109-2121.
2. Naldini, L., Blomer, U., Gage, F. H., Trono, D., and Verma, I. M. (1996). Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad. Sci. U. S. A. 93: 11382-11388.
3. Naldini, L., et al. (1996). In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272: 263-267.
4. Mitrophanous, K., et al. (1999). Stable gene transfer to the nervous system using a non-primate lentiviral vector. Gene Ther. 6: 1808-1818.
5. Watson, D. J., Kobinger, G. P., Passini, M. A., Wilson, J. M., and Wolfe, J. H. (2002). Targeted transduction patterns in the mouse brain by lentivirus vectors pseudotyped with VSV, Ebola, Mokola, LCMV, or MuLV envelope proteins. Mol. Ther. 5: 528-537.
6. Desmaris, N., et al. (2001). Production and neurotropism of lentivirus vectors pseudotyped with lyssavirus envelope glycoproteins. Mol. Ther. 4: 149-156.
7. Wool-Lewis, R. J., and Bates, P. (1998). Characterization of Ebola virus entry by using pseudotyped viruses: Identification of receptor-deficient cell lines. J. Virol. 72: 3155-3160.
8. Chan, S. Y., Speck, R. F., Ma, M. C., and Goldsmith, M. A. (2000). Distinct mechanisms of entry by envelope glycoproteins of Marburg and Ebola (Zaire) viruses. J. Virol. 74: 4933-4937.
9. Beyer, W. R., Westphal, M., Ostertag, W., and von Laer, D. (2002). Oncoretrovirus and lentivirus vectors pseudotyped with lymphocytic choriomeningitis virus glycoprotein: generation, concentration, and broad host range. J. Virol. 76: 1488-1495.
10. Mochizuki, H., Schwartz, J. P., Tanaka, K., Brady, R. O., and Reiser, J. (1998). High-titer human immunodeficiency virus type 1-based vector systems for gene delivery into nondividing cells. J. Virol. 72: 8873-8883.
11. Stitz, J., et al. (2000). Lentiviral vectors pseudotyped with envelope glycoproteins derived from gibbon ape leukemia virus and murine leukemia virus 10A1. Virology 273: 16-20.
12. Reiser, I., Harmison, G., Kluepfel-Stahl, S., Brady, R. O., Karlsson, S., and Schubert, M. (1996). Transduction of nondividing cells using pseudotyped defective high-titer HIV type 1 particles. Proc. Natl. Acad. Sci. U. S. A. 93: 15266-15271.
13. Kobinger, G. P., Weiner, D. J., Yu, Q. C., and Wilson, J. M. (2001). Filovirus-pseudotyped lentiviral vector can efficiently and stably transduce airway epithelia in vivo. Nat. Biotechnol. 19: 225-230.
14. Lewis, B. C., Chinnasamy, N., Morgan, R. A., and Varmus, H. E. (2001). Development of an avian leukosis-sarcoma virus subgroup A pseudotyped lentiviral vector. J. Virol. 75: 9339-9344.
15. Kang, Y., et al. (2002). In vivo gene transfer using a nonprimate lentiviral vector pseudotyped with Ross River virus glycoproteins. J. Virol. 76: 9378-9388.
16. Kobayashi, M., Iida, A., Ueda, Y., and Hasegawa, M. (2003). Pseudotyped lentivirus vectors derived from simian immunodeficiency virus SIVagm with envelope glycoproteins from paramyxovirus. J. Virol. 77: 2607-2614.
17. Ikeda, Y., Collins, M. K., Radcliffe, P. A., Mitrophanous, K. A., and Takeuchi, Y. (2002). Gene transduction efficiency in cells of different species by HIV and EIAV vectors. Gene Ther. 9: 932-938.
18. Carneiro, F. A., Bianconi, M. L., Weissmuller, G., Stauffer, F., and Da Poian, A. T. (2002). Membrane recognition by vesicular stomatitis virus involves enthalpy-driven protein lipid interactions. J. Virol. 76: 3756-3764.
19. Masters, P. S., Bhella, R. S., Butcher, M., Patel, B., Ghosh, H. P., and Banerjee, A. K. (1989). Structure and expression of the glycoprotein gene of Chandipura virus. Virology 171: 285-290.
20. Lafay, F., et al. (1991). Spread of the CVS strain of rabies virus and of the avirulent mutant AvO1 along the olfactory pathways of the mouse after intranasal inoculation. Virology 183: 320-330.
21. Coulon, P., Derbin, C., Kucera, P., Lafay, F., Prehaud, C., and Flamand, A. (1989). Invasion of the peripheral nervous systems of adult mice by the CVS strain of rabies virus and its avirulent derivative AvO1. J. Virol. 63: 3550-3554.
22. Dietzschold, B., et al. (1985). Differences in cell-to-cell spread of pathogenic and apathogenic rabies virus in vivo and in vitro. J. Virol. 56: 12-18.
23. Tuffereau, C., Benejean, J., Blondel, D., Kieffer, B., and Flamand, A. (1998). Low-affinity nerve-growth factor receptor (P75NTR) can serve as a receptor for rabies virus. EMBO J. 17: 7250-7259.
24. Thoulouze, M. I., Lafage, M., Schachner, M., Hartmann, U., Cremer, H., and Lafon, M. (1998). The neural cell adhesion molecule is a receptor for rabies virus. J. Virol. 72: 7181-7190.
25. Lentz, T. L. (1990). Rabies virus binding to an acetylcholine receptor alpha-subunit peptide. J. Mol. Recognit. 3: 82-88.
26. Hanham, C. A., Zhao, F., and Tignor, G. H. (1993). Evidence from the anti-idiotypic network that the acetylcholine receptor is a rabies virus receptor. J. Virol. 67: 530-542.
27. Gastka, M., Horvath, J., and Lentz, T. L. (1996). Rabies virus binding to the nicotinic acetylcholine receptor alpha subunit demonstrated by virus overlay protein binding assay. J. Gen. Virol. 77: 2437-2440.
28. Langevin, C., and Tuffereau, C. (2002). Mutations conferring resistance to neutralization by a soluble form of the neurotrophin receptor (p75NTR) map outside of the known antigenic sites of the rabies virus glycoprotein. J. Virol. 76: 10756-10765.
29. Lalli, G., and Schiavo, G. (2002). Analysis of retrograde transport in motor neurons reveals common endocytic carriers for tetanus toxin and neurotrophin receptor p75NTR. J. Cell Biol. 156: 233-239.
30. Bronfman, F. C., Tcherpakov, M., Jovin, T. M., and Fainnzilber, M. (2003). Ligand-induced internalization of the p75 neurotrophin receptor: a slow route to the signaling endosome. J. Neurosci. 23: 3209-3220.
31. Azzouz, M., et al. (2002). Multicistronic lentiviral vector-mediated stratal gene transfer of aromatic I-amino acid decarboxylase, tyrosine hydroxylase, and GTP cyclohydrolase I induces sustained transgene expression, dopamine production, and functional improvement in a rat model of Parkinson's disease. J. Neurosci. 22: 10302-10312.
32. Lilley, C. E., et al (2001). Multiple immediate-early gene-deficient herpes simplex virus vectors allowing efficient gene delivery to neurons in culture and widespread gene delivery to the central nervous system in vivo. J. Virol. 75: 4343-4356.
33. Wood, M. J., Byrnes, A. P., Kaplitt, M. G., Pfaff, D. W., Rabkin, S. D., and Charlton, H. M. (1994). Specific patterns of defective HSV-1 gene transfer in the adult central nervous system: implications for gene targeting. Exp. Neurol. 130: 127-140.
34. Ghadge, G. D., et al. (1995). CNS gene delivery by retrograde transport of recombinant replication-defective adenoviruses. Gene Ther. 2: 132-137.
35. Kaspar, B. K., Erickson, D., Schaffer, D., Hinh, L., Gage, F. H., and Peterson, D. A. (2002). Targeted retrograde gene delivery for neuronal protection. Mol. Ther. 5: 50-56.
36. Bienemann, A. S., et al. (2003). Long-term replacement of a mutated nonfunctional CNS gene: reversal of hypothalamic diabetes insipidus using an EIAV-based lentiviral vector expressing arginine vasopressin. Mol. Ther. 7: 588-596.
37. Rohll, J. B., et al. (2002). Design, production, safety, evaluation, and clinical applications of nonprimate lentiviral vectors. Methods Enzymol. 346: 466-500.
38. Martin-Rendon, E., White, L. J., Olsen, A., Mitrophanous, K. A., and Mazarakis, N. D. (2002). New methods to titrate EIAV-based lentiviral vectors. Mol. Ther. 5: 566-570.
39. Abercrombie, M. (1946). Estimation of nuclear populations from microtome sections. Anat. Rec. 94: 239-247.